Back to results
CompletedPhase 1Phase 2

Study to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients

NCT05887466

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Yonsei University Health System, Severance Hospital

Seoul, South Korea

View on ClinicalTrials.gov
Study to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients — TrialFind